Ischemic stroke: From pathological mechanisms to neuroprotective strategies
Ischemic stroke (IS) has complex pathological mechanisms, and is extremely difficult to treat. At present, the treatment of IS is mainly based on intravenous thrombolysis and mechanical thrombectomy, but they are limited by a strict time window. In addition, after intravenous thrombolysis or mechani...
Main Authors: | Yang Jiang, Zhenquan Liu, Yan Liao, Shuyong Sun, Yajie Dai, Yibo Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2022.1013083/full |
Similar Items
-
Excitatory Synaptic Transmission in Ischemic Stroke: A New Outlet for Classical Neuroprotective Strategies
by: Fan Wang, et al.
Published: (2022-08-01) -
Neuroprotective Effects of Quercetin on Ischemic Stroke: A Literature Review
by: Leilei Zhang, et al.
Published: (2022-05-01) -
The CD31 molecule: a possible neuroprotective agent in acute ischemic stroke?
by: Tobias Boeckh-Behrens, et al.
Published: (2017-04-01) -
High Actin Expression in Thrombus of Acute Ischemic Stroke Can Be a Biomarker of Atherothrombotic Origin Stroke
by: Rongyu Wang, et al.
Published: (2022-07-01) -
Detecting prokaryote-specific gene and other bacterial signatures in thrombi from patients with acute ischemic stroke
by: Xiaoke Wang, et al.
Published: (2024-01-01)